RecallRadar

FDA Drug recall D-0660-2026

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsule…

On 2026-07-08 the FDA classified a Class II recall of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsule… by Lannett, citing labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0660-2026
ClassificationClass II
Statusongoing
Initiated2026-06-26
Published2026-07-08
Last updated2026-09-13 11:52 UTC
CompanyLannett
DistributionUS

Product

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

Reason

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Identifiers

ndc0527-0790-37
ndc0527-0791-37
ndc0527-0792-37
ndc0527-0793-37
ndc0527-0794-37
ndc0527-0795-37
code_infoLot#: 25285401A, Exp. Date: 04/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0660-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.